Produkty
Producenci
Bevacizumab Lyophilized powder
Opis
Produkt przeznaczony wyłącznie do badań. Nie nadaje się do spożycia. Więcej informacji na stronie producenta www.toku-e.com
Bevacizumab is an angiogenesis inhibiting monoclonal antibody and is commonly used to treat certain metastatic cancers.
Cas Number: 216974-75-3
Molecular Formula: C6638H10160N1720O2108S44
Molecular Weight: 149,146.82 g/mol
Mechanism of Action: Bevacizumab can inhibit tumor growth in a few different ways including inhibiting new blood vessel growth, altering vascular function and blood flow in tumor, and regression of newly formed tumor vasculature.
Storage Conditions: ≤30°C
Spectrum: Bevacizumab is effective at treating metastatic colon cancer, lung cancers, renal cancers, ovarian cancers, and breast cancer.
Purity Level: (HPLC): Not less than 98.0%
References: Ellis, Lee M. "Mechanisms of Action of Bevacizumab as a Component of Therapy for Metastatic Colorectal Cancer." Seminars in Oncology 33 (2006)
Dane techniczne
| Opakowanie | 5 mg |